*Cardiology Department, Fundación Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Complejo Hospitalario Universidad de Santiago de Compostela, Santiago de Compostela, Spain;

†Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain;

‡Cardiology Department, Hospital Universitario de San Juan, Alicante, Spain;

§Unidad de Investigación en Cardiología, Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO), Valencia, Spain;

¶Cardiology Department, Hospital Universitario de Jaén, Jaén, Spain;

‖Cardiology Department, Hospital Alto Guadalquivir, Jaén, Spain;

**Cardiology Department, Consorcio Hospital General de Valencia, Valencia, Spain;

††University of Santiago de Compostela (USC), Spain;

‡‡Management Department, Complejo Hospitalario Universidad de Santiago de Compostela, Santiago de Compostela, Spain;

§§Cardiology Department, Parc Sanitari Sant Joan de Déu, Sant Boi de Llobregat, Barcelona, Spain;

¶¶Cardiology Department, Hospital Universitario de Cabueñes, Gijón, Spain;

‖‖Cardiology Department, Hospital de Alava, Vitoria, Spain;

***Cardiology Department, Hospital Universitario de Denia, Denia, Spain;

†††Cardiology Department, Hospital General Universitario de Alicante, Alicante, Spain;

‡‡‡Cardiology Department, Hospital Sant Joan Despí Moisès Broggi, Sant Joan Despí, Barcelona. Spain;

§§§Cardiology Department, Hospital del Vall Hebrón, Barcelona, Spain;

¶¶¶Cardiology Department, Hospital Virgen del Puerto de Plasencia, Plasencia. Spain;

‖‖‖Cardiology Department, Hospital Hospital Lluis Alcanys Xátiva, Valencia, Spain; and

****Cardiology Department, Hospital Manacor, Palma de Mallorca, Spain.

Correspondence: Alberto Cordero, MD, PhD, FESC, Cardiology Department, Hospital Universitario de San Juanangel, Carretera Valencia-Alicante sn, 03550 San Juan de Alicante, Alicante, Spain (e-mail: [email protected]).

Investigators received the support of the National Network for Biomedical Cardiovascular Research of Cardiovascular Disease (CIBERCV, Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares).

Authors declare that there are no conflicts of interest related to the results of this study. Dr. Alberto Cordero reports (a) honoraria for lectures from AstraZeneca, Bristol-Myers Squibb, Boehringer Ingelheim, Ferrer, Mylan, Sanofi, and AMGEN and (b) consulting fees from AstraZeneca, Sanofi, Ferrer, and AMGEN.

Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Web site (www.jcvp.org).